资产负债表（Madrigal Pharmaceuticals Inc）
| 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|
| 截止日期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 流动资产： | ||||||||
| 现金及现金等价物(元) | 99,915,000.00 | 62,055,000.00 | 77,196,000.00 | 113,308,000.00 | 331,549,000.00 | 59,340,000.00 | 53,272,000.00 | 42,282,000.00 |
| 预付款项及其他应收款流动(元) | 3,150,000.00 | 3,118,000.00 | 3,177,000.00 | 1,807,000.00 | 2,595,000.00 | 3,920,000.00 | 2,780,000.00 | 1,217,000.00 |
| 短期投资(元) | 534,216,000.00 | 170,296,000.00 | 221,222,000.00 | 216,169,000.00 | 27,225,000.00 | 93,852,000.00 | 158,494,000.00 | 177,671,000.00 |
| 流动资产合计(元) | 637,281,000.00 | 235,469,000.00 | 301,595,000.00 | 331,284,000.00 | 361,369,000.00 | 157,112,000.00 | 214,546,000.00 | 221,170,000.00 |
| 非流动资产： | ||||||||
| 物业、厂房及设备(元) | 1,553,000.00 | 659,000.00 | 455,000.00 | 512,000.00 | 601,000.00 | 701,000.00 | 789,000.00 | 796,000.00 |
| 非流动资产其他项目(元) | 1,713,000.00 | 1,836,000.00 | 411,000.00 | 653,000.00 | 602,000.00 | 831,000.00 | 1,057,000.00 | 696,000.00 |
| 非流动资产合计(元) | 3,266,000.00 | 2,495,000.00 | 866,000.00 | 1,165,000.00 | 1,203,000.00 | 1,532,000.00 | 1,846,000.00 | 1,492,000.00 |
| 总资产(元) | 640,547,000.00 | 237,964,000.00 | 302,461,000.00 | 332,449,000.00 | 362,572,000.00 | 158,644,000.00 | 216,392,000.00 | 222,662,000.00 |
| 流动负债： | ||||||||
| 融资租赁负债流动(元) | 527,000.00 | 513,000.00 | 411,000.00 | 653,000.00 | 602,000.00 | 760,000.00 | - | - |
| 应付账款及票据(元) | 28,041,000.00 | 16,542,000.00 | 17,534,000.00 | 12,128,000.00 | 23,831,000.00 | 18,562,000.00 | 11,294,000.00 | 22,780,000.00 |
| 其他应付款及应计费用(元) | 89,980,000.00 | 82,610,000.00 | 81,761,000.00 | 85,567,000.00 | 91,461,000.00 | 79,598,000.00 | 71,836,000.00 | 53,442,000.00 |
| 流动负债其他项目(元) | - | - | - | - | - | - | 879,000.00 | 413,000.00 |
| 流动负债合计(元) | 118,548,000.00 | 99,665,000.00 | 99,706,000.00 | 98,348,000.00 | 115,894,000.00 | 98,920,000.00 | 84,009,000.00 | 76,635,000.00 |
| 非流动负债： | ||||||||
| 长期债务(元) | - | 114,727,000.00 | - | - | - | - | - | - |
| 融资租赁负债非流动(元) | 1,186,000.00 | 1,323,000.00 | - | - | - | 71,000.00 | 178,000.00 | 283,000.00 |
| 非流动负债其他项目(元) | 115,480,000.00 | - | 99,249,000.00 | 83,965,000.00 | 49,289,000.00 | 48,983,000.00 | 48,670,000.00 | - |
| 非流动负债合计(元) | 116,666,000.00 | 116,050,000.00 | 99,249,000.00 | 83,965,000.00 | 49,289,000.00 | 49,054,000.00 | 48,848,000.00 | 283,000.00 |
| 总负债(元) | 235,214,000.00 | 215,715,000.00 | 198,955,000.00 | 182,313,000.00 | 165,183,000.00 | 147,974,000.00 | 132,857,000.00 | 76,918,000.00 |
| 股东权益： | ||||||||
| 普通股(元) | 2,000.00 | 2,000.00 | 2,000.00 | 2,000.00 | 2,000.00 | 2,000.00 | 2,000.00 | 2,000.00 |
| 股本溢价(元) | 1,741,153,000.00 | 1,246,385,000.00 | 1,228,949,000.00 | 1,189,776,000.00 | 1,160,079,000.00 | 887,660,000.00 | 879,538,000.00 | 870,972,000.00 |
| 留存收益(元) | -1,336,290,000.00 | -1,224,096,000.00 | -1,125,356,000.00 | -1,039,556,000.00 | -962,660,000.00 | -876,755,000.00 | -795,558,000.00 | -724,828,000.00 |
| 累计其他全面收益(元) | 468,000.00 | -42,000.00 | -89,000.00 | -86,000.00 | -32,000.00 | -237,000.00 | -447,000.00 | -402,000.00 |
| 归属于母公司股东权益(元) | 405,333,000.00 | 22,249,000.00 | 103,506,000.00 | 150,136,000.00 | 197,389,000.00 | 10,670,000.00 | 83,535,000.00 | 145,744,000.00 |
| 股东权益合计(元) | 405,333,000.00 | 22,249,000.00 | 103,506,000.00 | 150,136,000.00 | 197,389,000.00 | 10,670,000.00 | 83,535,000.00 | 145,744,000.00 |
| 负债及股东权益合计(元) | 640,547,000.00 | 237,964,000.00 | 302,461,000.00 | 332,449,000.00 | 362,572,000.00 | 158,644,000.00 | 216,392,000.00 | 222,662,000.00 |
| 公告日期 | 2024-02-28 | 2023-11-06 | 2023-08-08 | 2023-05-09 | 2023-02-23 | 2022-11-03 | 2022-08-04 | 2022-05-09 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | ||||||||
| 核数师 |